SCHEMBL6803579

SCHEMBL6803579

CC[C@@H]1CC1[C@@H](C)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6803578 1.00
SCHEMBL19015346 1.00
SCHEMBL6806943 1.00
SCHEMBL15314428 0.81 OGA (0.38)
SCHEMBL12611560 0.80
SCHEMBL1788068 0.80
SCHEMBL14231066 0.80
SCHEMBL18410900 0.78
SCHEMBL21017184 0.74
SCHEMBL18314622 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119059879-A Cyclopropanation of substituted olefins 国际香料和香精公司 2024-12-03 CN disclosed
US-8461196-B2 1-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disorders DOV PHARMACEUTICAL 2013-06-11 US disclosed
US-20040171534-A1 GRF analogs with increased biological potency THERATECHNOLOGIES, INC. (CA) 2004-09-02 US disclosed
US-6458764-B1 CHIMERIC FATTY BODY-GRF ANALOGS WITH INCREASED BIOLOGICAL POTENCY, THEIR APPLICATION AS ANABOLIC AGENTS AND IN THE DIAGNOSIS AND TREATMENT OF GROWTH HORMONE DEFICIENCIES. THE CHIMERIC FATTY BODY-GRF ANALOGS INCLUDE AN HYDROPHOBIC MOIETY THERATECHNOLOGIES INC. (CA) 2002-10-01 US disclosed